Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors-Reference-Cited by-同舟云学术

Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors

Published:2009-04-17 Issue:14 Volume:18 Page:2543-2554
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:Human Molecular Genetics

Author:

Anastasaki C.,Estep A. L.,Marais R.,Rauen K. A.,Patton E. E.

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/18/14/2543/1664366/ddp186.pdf

Reference42 articles.

1. Noonan, Costello and cardio–facio–cutaneous syndromes: dysregulation of the Ras–MAPK pathway

2. Targeting the mitogen-activated protein kinase cascade to treat cancer

3. Mutations of the BRAF gene in human cancer

4. Mechanisms of drug inhibition of signalling molecules

5. Advances in the Development of Cancer Therapeutics Directed against the RAS-Mitogen-Activated Protein Kinase Pathway: Fig. 1.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Mammalian Models for Understanding Neurological Defects in RASopathies;Biomedicines;2024-04-10

2. Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor;Molecular Medicine;2024-04-09

3. Erratum for the Research Article: “Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish”;Science Advances;2023-11-24

4. The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic–Therapeutic Implications;Genes;2023-11-22

5. RAS pathway: The new frontier of brain mosaicism in epilepsy;Neurobiology of Disease;2023-05